FT Vest U.S. Equity Buffer ETF - March (FMAR) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free FMAR Stock Alerts $38.63 +0.26 (+0.68%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipStock AnalysisChartHoldingsOwnership FT Vest U.S. Equity Buffer ETF - March Stock Price Performance5 Day Performance+1.93%1 Month Performance-1.00%3 Month Performance+1.15%6 Month Performance+12.00%Year-To-Date Performance+2.32%1 Year Performance+15.69% Receive FMAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FT Vest U.S. Equity Buffer ETF - March and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> FMAR Stock Chart for Friday, April, 26, 2024 FMAR Chart by TradingView FT Vest U.S. Equity Buffer ETF - March Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$38.37$38.63+0.68%$38.70$38.56196,488 shs$659.80 million04/25/2024$38.44$38.37-0.18%$38.39$38.0349,739 shs$655.36 million04/24/2024$38.47$38.44-0.06%$38.54$38.34271,480 shs$656.56 million04/23/2024$38.17$38.47+0.77%$38.50$38.3433,660 shs$656.98 million04/22/2024$37.90$38.17+0.71%$38.28$37.9274,968 shs$651.94 million04/19/2024$38.31$37.87-1.16%$38.14$37.83163,012 shs$313.14 million Get the Latest News and Ratings for FMAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FT Vest U.S. Equity Buffer ETF - March and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$38.20$38.31+0.29%$38.34$38.0777,954 shs$316.82 million04/17/2024$38.37$38.20-0.44%$38.45$38.1194,344 shs$315.91 million04/16/2024$38.86$38.37-1.26%$38.41$38.2537,831 shs$317.32 million04/15/2024$38.66$38.86+0.52%$38.89$38.3263,735 shs$321.37 million04/12/2024$39.03$38.63-1.02%$38.88$38.60134,855 shs$319.47 million04/11/2024$38.87$39.03+0.41%$39.07$38.7353,073 shs$322.78 million04/10/2024$39.06$38.87-0.47%$38.91$38.7392,680 shs$321.46 million04/09/2024$39.04$39.06+0.04%$39.14$38.8347,969 shs$322.99 million04/08/2024$39.04$39.04$39.10$39.0050,027 shs$322.86 million04/05/2024$38.81$39.04+0.59%$39.10$38.8452,593 shs$322.86 million04/04/2024$39.06$38.81-0.64%$39.27$38.7763,026 shs$320.96 million04/03/2024$38.95$39.06+0.28%$39.15$38.9698,232 shs$323.03 million04/02/2024$39.19$38.95-0.61%$39.05$38.91191,793 shs$322.12 million04/01/2024$39.24$39.19-0.13%$39.32$39.11118,619 shs$324.10 million03/29/2024$39.27$39.24-0.08%$39.29$39.2185,141 shs$324.52 million03/28/2024$39.24$39.27+0.08%$39.29$39.2185,141 shs$324.76 million03/27/2024$39.02$39.24+0.56%$39.24$39.0786,002 shs$324.52 million03/26/2024$39.05$39.02-0.06%$39.16$39.01440,301 shs$322.70 million03/25/2024$39.14$39.05-0.24%$39.13$39.04420,310 shs$322.90 million03/22/2024$39.18$39.18$39.22$39.13149,207 shs$324.02 million03/21/2024$39.12$39.18+0.15%$39.27$39.16296,473 shs$324.02 million03/20/2024$38.90$39.12+0.57%$39.13$38.831.14 million shs$323.52 million03/19/2024$38.78$38.90+0.31%$38.91$38.66944,078 shs$321.70 million03/18/2024$38.64$38.78+0.36%$38.88$38.73349,759 shs$320.71 million03/15/2024$38.60$38.64+0.10%$38.64$38.59643,456 shs$319.55 million03/14/2024$38.59$38.60+0.03%$38.62$38.5850,015 shs$319.22 million03/13/2024$38.59$38.59$38.62$38.5327,584 shs$319.14 million03/12/2024$38.58$38.59+0.03%$38.62$38.5829,281 shs$319.14 million03/11/2024$38.57$38.58+0.03%$38.60$38.5518,559 shs$319.06 million03/08/2024$38.53$38.57+0.10%$38.58$38.5419,692 shs$318.97 million03/07/2024$38.53$38.530.00%$38.58$38.50130,128 shs$318.64 million03/06/2024$38.52$38.53+0.03%$38.57$38.5113,494 shs$318.65 million03/05/2024$38.54$38.52-0.05%$38.56$38.529,515 shs$318.56 million03/04/2024$38.49$38.54+0.13%$38.54$38.4717,927 shs$318.73 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$38.50$38.50+0.01%$38.54$38.4912,782 shs$318.40 million02/29/2024$38.51$38.50-0.04%$38.52$38.505,928 shs$318.35 million02/28/2024$38.48$38.51+0.08%$38.52$38.441,353 shs$318.48 million02/27/2024$38.45$38.48+0.08%$38.52$38.453,963 shs$318.23 million02/26/2024$38.47$38.45-0.05%$38.51$38.4333,712 shs$317.98 million02/23/2024$38.41$38.44+0.08%$38.51$38.4410,510 shs$317.90 million02/22/2024$38.39$38.41+0.06%$38.46$38.40463,369 shs$317.65 million02/21/2024$38.39$38.39+0.01%$38.42$38.36168,177 shs$317.47 million02/20/2024$38.40$38.39-0.04%$38.42$38.358,376 shs$317.45 million02/19/2024$38.40$38.40$38.44$38.3714,792 shs$317.57 million02/16/2024$38.36$38.38+0.05%$38.42$38.3814,792 shs$317.40 million02/15/2024$38.34$38.36+0.05%$38.39$38.337,554 shs$317.24 million02/14/2024$38.29$38.34+0.13%$38.37$38.314,935 shs$317.07 million02/13/2024$38.34$38.29-0.13%$38.35$38.2418,826 shs$316.66 million02/12/2024$38.36$38.34-0.05%$38.37$38.342,961 shs$317.07 million02/09/2024$38.31$38.36+0.13%$38.36$38.321,036 shs$317.24 million02/08/2024$38.31$38.31+0.01%$38.35$38.303,477 shs$316.82 million02/07/2024$38.26$38.31+0.12%$38.32$38.298,933 shs$316.78 million02/06/2024$38.26$38.26$38.32$38.2517,804 shs$316.41 million02/05/2024$38.29$38.26-0.08%$38.28$38.213,992 shs$316.41 million02/02/2024$38.20$38.29+0.25%$38.29$38.229,305 shs$316.66 million02/01/2024$38.18$38.20+0.04%$38.22$38.161,544 shs$315.87 million01/31/2024$38.19$38.18-0.03%$38.20$38.163,102 shs$315.75 million01/30/2024$38.21$38.19-0.05%$38.23$38.185,009 shs$315.83 million01/29/2024$38.20$38.21+0.03%$38.21$38.147,845 shs$316.00 million01/26/2024$38.17$38.19+0.05%$38.20$38.147,061 shs$315.83 million01/25/2024$38.14$38.17+0.08%$38.17$38.116,491 shs$315.67 million Related Companies: GSEW Stock Price Chart SPXU Stock Price Chart SFY Stock Price Chart FJUL Stock Price Chart SPXS Stock Price Chart PSEP Stock Price Chart PMAR Stock Price Chart BALT Stock Price Chart LGLV Stock Price Chart UDOW Stock Price Chart Receive FMAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for FT Vest U.S. Equity Buffer ETF - March and its competitors with MarketBeat's FREE daily newsletter. This page (BATS:FMAR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FT Vest U.S. Equity Buffer ETF - March Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.